Moon Surgical Archives - Medical Design Sourcing

10 surgical robotics companies you need to know

The surgical robotics space saw a major shakeup last year. The da Vinci SP surgical robotics system [Image courtesy of Intuitive Surgical]“Robotics is hard. Robotics in healthcare is hard.”

Hani Abouhalka, Johnson & Johnson’s company group chair for Robotics & Digital, said those words at our DeviceTalks West event in California in October.

It pretty much sums up the situation for medtech companies large and small that sought to compete against Intuitive in the soft-tissue surgical robotics space. Despite the increased competition, Intuitive remains the undisputed leader. It’s even moving forward on a next-gen da Vinci robot.

For its part, Johnson & Johnson is sticking with plans to develop its Ottava surgical robot. J&J now plans to submit Ottava for FDA investigational device exemption (IDE) in the second half of 2024 in order to start clinical trials.

Even though it is sticking with robotic surgery, J&J laid off employees in th…

November 2023 Medical Device Handbook: Breaking new ground in medtech

How Abbott designed the world’s first dual-chamber leadless pacemaker system

J&J used RWE for expanded indications — and you can, too

Moon Surgical thinks Maestro’s light touch can win the surgical robotics arms race

Breaking new ground in medtech

This year has brought a flurry of firsts from medical device manufacturers as they develop new and improved products despite continued supply chain and economic challenges.

These device innovations have been in the works for years, pushed forward by teams ranging from small startups to the world’s largest medtech companies — and all with help from outsourcing partners.

All of these industry players have come together once again in our latest edition of the Medical Design & Outsourcing Medical Device Handbook to offer uniquely relevant and actionable advice for device designers and engineers.

This edit…

First U.S. clinical cases performed with Moon Surgical’s Maestro surgical robot

The Maestro surgical robot. [Image courtesy of Moon Surgical]Moon Surgical announced today that a hospital in Florida performed the first U.S. clinical procedures with its Maestro surgical robot.

The procedures took place at Baptist Health in Jacksonville, Florida. Dr. Steven Hodgett, Dr. Craig Morgenthal and Dr. Alexander Rose performed the surgeries. They conducted sleeve gastrectomies, the most common bariatric (weight loss) surgery.

Moon Surgical’s latest U.S. milestone comes around nine months after it received FDA clearance for Maestro in December 2022.

“The Maestro System is an asset to my laparoscopy practice,” said Hodgett, medical director, Baptist Center for Bariatric and Reflux Surgery. “During procedures, the two co-manipulative arms provided me with stable vision and dependable organ retraction, allowing me to give more focus to my surgical case and perform at my best.”

More about Moon Surgical and Maestro

Paris-based Moon Surgica…

Moon Surgical picks up CE mark for updated Maestro surgical robot

The Maestro surgical robot. [Image courtesy of Moon Surgical]Moon Surgical announced today that it received CE mark approval in Europe for the latest version of its Maestro surgical robot system.

The initial version of Maestro received CE mark approval earlier this year in April. This milestone marks the latest in a string of positive updates for Moon Surgical, which raised $55.4 million in May. The company also announced at that time that it appointed surgical robotics veteran Fred Moll to its board.

Paris-based Moon Surgical says the updated Maestro system features enhanced scalability and refined aesthetics. Other improvements over its previous iteration include an automated set-up with bedside guidance and tailored surgeon configurations.

Additionally, the new Maestro features cloud connectivity for a more integrated operating room and ecosystem experience. It provides surgeon-guided, hands-free scope control for optimized vision capabilities.

Mo…

Find solutions to your most demanding medtech problem at DeviceTalks West

Add some essentials to your toolbox with engineering expertise from our upcoming show in California.

Intuitive President Dave Rosa will give a keynote interview at DeviceTalks West 2023. [Photo courtesy of Intuitive]

In the medical device industry, stubborn problems can cost millions in development expenses and delay the introduction of new life-saving tools and technologies.

That’s why we build our DeviceTalks meetings as a forum where successful medical device engineers, manufacturers and market-builders can share their best practices, providing solutions that help clear hurdles, speed product development and potentially save lives.

DeviceTalks attendees leave our meeting with notebooks full of critical advice and pockets full of business cards. We’ll help fill both at DeviceTalks West, which takes place Oct. 18-19 at the Santa Clara Convention Center in California. You can view the full agenda on our…

Moon Surgical thinks Maestro’s light touch can win the surgical robotics arms race

A surgeon using the Moon Surgical Maestro surgical robotics system [Photo courtesy of Moon Surgical]

The Moon Surgical Maestro robotic surgery system faces some stiff competition — and the device developer plans to use that to its advantage.

In an interview with Medical Design & Outsourcing, Moon Surgical CEO Ann Osdoit and Chief Technology Officer David Noonan discussed the technology behind what they described as their system’s key benefit: the ability to collaborate with surgeons.

“We’ve built a collaborative robot, which is not necessarily what you typically see out there in the market,” Noonan said. “[Most] robot arms are extremely stiff. If you want to try and grab a hold of that and use it to manipulate it, you can’t because the payload and the stiffness is what’s needed to execute the task.”

But Maestro is designed to let surgeons directl…

Artificial intelligence: What medtech’s top influencers think

Artificial intelligence’s effect on medtech was a question that came up continually during our DeviceTalks Boston show in early May.

Here is what some of the top influencers in the industry had to say:

Boston Scientific CEO Mike Mahoney [Photo courtesy of Boston Scientific]

Boston Scientific CEO Mike Mahoney on artificial intelligence and medtech

“I’ll give you some practical applications. … We have manufacturing plants around the world, and we have great quality systems, and we have great quality engineers who inspect everything, and we have a zillion microscopes looking at every little product that we have all over the world. Our team is leveraging AI capabilities for visualization inspection rather than the human eye constantly doing that with the mistakes that are inherent and scrapping products and so forth. … We’re seeing cost productivity and better quality by just leveraging AI in our…

Moon Surgical raises $55.4M to support surgical robot platform, names Fred Moll board chair

The Maestro surgical robot. [Image courtesy of Moon Surgical]Moon Surgical announced today that it raised $55.4 million and appointed a surgical robotics veteran as the chair of its board.

The French-American company develops the Maestro system to support surgeons in soft tissue surgical procedures. The platform acts as a robotic surgical assistant to augment the precision and control of laparoscopic surgery.

Moon Surgical’s small, adaptable system can integrate into existing clinical workflows. It features capabilities that bolster operating room efficiency and allow for alternative labor models.

The company earmarked its latest fundraising to support the continued development and planned commercialization for Maestro. Moon Surgical received FDA 510(k) clearance for Maestro in December 2022, followed by CE mark last month. In June 2022, Moon Surgical completed a $31.3 million Series A fundraising.

Sofinnova Partners co-led …

Surgical robotics trends and how to accelerate adoption

Moon Surgical Chief Strategy Officer Jeffery Alvarez. [Photo courtesy of Moon Surgical]

Some of the biggest names in the development of surgical robotics systems and virtual reality training technology discussed robotic surgery trends at DeviceTalks Boston.

Moon Surgical Chief Strategy Officer Jeffery Alvarez, Stryker Digital, Robotics, and Enabling Technologies President Robert Cohen, Osso VR CEO Justin Barad and FundamentalVR CEO and co-founder Richard Vincent see rapid changes ahead for surgical robotics and opportunities to win over surgeons, health systems and patients.

We’ve curated excerpts from the conversation, lightly edited for clarity and space.

Trends in surgical robotics

Alvarez: “There’s a transition from building robots that are hyper-specialized in one thing and do one thing really well, to platforms that are looking at how to solve bigger parts of the problem: H…

How these engineers make DeviceTalks Boston go!

We love engineers of all types — here are a just a few you’ll meet at DeviceTalks Boston.

We love engineers here at DeviceTalks.

It’s obvious why. Engineers are the straw that stirs medtech’s drink (apologies to Reggie Jackson). Nothing happens — financing, manufacturing, approval, help for patients — without a well-conceived product.

And engineers often transcend their typical design roles. They grow into business leaders, technology evangelists, startup CEOs, and yes, some stay to lead ground-breaking research and development groups.

So I’m thrilled to be bringing engineers of all types into the agenda of DeviceTalks Boston. We’ll have engineers from Abbott, ZimVie, Philips, Boston Scientific, Stryker and many other companies on hand to talk about being an engineer.

But we’ll also hear from engineers who have followed their careers into other parts of the medical device industry.

In this column, we’ll walk you through some of their …

Moon Surgical completes first-in-human clinical study of surgical robot

The Maestro surgical robot. [Image courtesy of Moon Surgical]Moon Surgical announced today that it successfully completed 30 first-in-human laparoscopy procedures with its Maestro surgical robot.

It marks more good news for the French company, which last week won FDA clearance for Maestro. The clearance offers support to surgeons in soft tissue surgical procedures.

Moon Surgical designed Maestro for soft tissue procedures not currently supported by telerobotic systems. The small, adaptable system can integrate into existing clinical workflows and provide the surgeon with more control.

The Maestro system also increases operating room efficiency by enhancing surgical instruments and techniques. It also minimizes the impact on operating room turnover time, according to a news release.

Dr. Guy-Bernard Cadière performed all 30 procedures. They took place at CHU Saint-Pierre, a public university hospital in Brussels, Belgium.

“I am thrilled to…

Moon Surgical wins first FDA 510(k) clearance for surgical robot

This screen grab from a Moon Surgical marketing video gives an idea of what the Maestro robotic surgery system looks like in action [Image courtesy of Moon Surgical]Moon Surgical announced today that it received FDA 510(k) clearance for its Maestro surgical robotics system.

Paris- and San Francisco-based Moon Surgical designed Maestro to support surgeons in soft tissue surgical procedures. Think of it as a robotic surgical assistant.

The small, adaptable system can integrate into existing clinical workflows. It features capabilities that bolster operating room efficiency and allow for alternative labor models, the company said.

In June, Moon Surgical completed a $31.3 million Series A fundraising. CEO Ann Osdoit said the company aims to make Maestro capable of use in any laparoscopy in any operating room. This could revolutionize minimally invasive surgery through collaborative and adaptive robotics.

Moon Surgical featured…